LUTHERAN MUSCULOSKELETAL CENTER
1. Target Overview & Investment Thesis
LUTHERAN MUSCULOSKELETAL CENTER is a 39-bed suburban community hospital in nan, IN with $168.9M in net patient revenue and a 25.0% operating margin. The hospital serves a payer mix of 23.0% Medicare, 8.6% Medicaid, and 68.5% commercial.
Thesis: Turnaround. Our ML models identify $12.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.0% to 32.3% (+736bps).
| Net Revenue HCRIS | $168.9M |
| Current EBITDA COMPUTED | $42.2M |
| Operating Margin COMPUTED | 25.0% |
| Occupancy HCRIS | 26.9% |
| Revenue / Bed COMPUTED | $4.3M |
| Net-to-Gross HCRIS | 17.8% |
| Distress Probability ML | 48.2% |
2. Market Context & Competitive Position
IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 25.0% places it above the state median. Among 89 size-comparable peers (20-78 beds), the median margin is -2.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (20-78), prioritizing same-state peers. 89 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LUTHERAN MUSCULOSKELETAL CENTE (Target) | IN | 39 | $168.9M | 25.0% |
| INDIANA ORTHOPAEDIC HOSPITAL L | IN | 38 | $196.8M | 31.2% |
| LAPORTE HOSPITAL | IN | 74 | $192.4M | 19.3% |
| SCHNECK MEDICAL CENTER | IN | 60 | $184.2M | -0.8% |
| ORTHOPAEDIC HOSPT.AT PARKVIEW | IN | 37 | $175.7M | 36.8% |
| WITHAM MEMORIAL HOSPITAL | IN | 50 | $158.5M | -11.6% |
| MAJOR HOSPITAL | IN | 46 | $156.9M | -9.2% |
| KOSCIUSKO COMMUNITY HOSPITAL | IN | 72 | $148.0M | 29.9% |
| FRANCISCAN HEALTH MUNSTER | IN | 78 | $139.8M | -5.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $108K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $42.2M |
| + RCM Uplift | +$12.4M |
| Pro Forma EBITDA | $54.6M |
| Current Margin | 25.0% |
| Pro Forma Margin | 32.3% |
| WC Released (1x) | $6.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $64.9M | $402.7M | 6.20x | 44.0% |
| Base (11x exit) | 10.0x | 11.0x | $64.9M | $464.0M | 7.15x | 48.2% |
| Bull Case | 9.0x | 11.0x | $58.4M | $526.1M | 9.00x | 55.2% |
| Bull (12x exit) | 9.0x | 12.0x | $58.4M | $591.2M | 10.12x | 58.9% |
| Bear Case | 11.0x | 10.0x | $71.4M | $319.4M | 4.47x | 34.9% |
| Bear (11x exit) | 11.0x | 11.0x | $71.4M | $374.6M | 5.24x | 39.3% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 26.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 89 hospitals with 20-78 beds
- Same-state prioritization (n=90)
- Comp margins: P25=-11.9% / P50=-2.9% / P75=7.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.